TY - JOUR
T1 - Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor
AU - Xu, Jun
AU - Wang, Qinggong
AU - Hübner, Harald
AU - Hu, Yunfei
AU - Niu, Xiaogang
AU - Wang, Haoqing
AU - Maeda, Shoji
AU - Inoue, Asuka
AU - Tao, Yuyong
AU - Gmeiner, Peter
AU - Du, Yang
AU - Jin, Changwen
AU - Kobilka, Brian K.
N1 - Funding Information:
We thank the Cryo-Electron Microscopy Center, the Chinese University of Hong Kong (Shenzhen) for their support of cryo-EM data collection; Kayo Sato, Shigeko Nakano, and Ayumi Inoue at Tohoku University for the NanoBiT assay and the flow cytometry experiment. This work was supported by the Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University; by the German Research Foundation (GRK1910 to P.G.) and by the American Heart Association Postdoctoral Fellowship (H.W.). All NMR experiments were performed at the Beijing NMR Center and the NMR facility of the National Center for Protein Sciences at Peking University, supported by the Grant 2016YFA0501201 from the National Key R&D Program of China to C. J.; Y.D. is supported by a grant from Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20200109150019113), Shenzhen Bay Open Project (SZBL2020090501011) and a Presidential Fellowship at the Chinese University of Hong Kong (Shenzhen). A.I. was funded by the PRIME 19gm5910013, the LEAP 20gm0010004, and the BINDS JP20am0101095 from the Japan Agency for Medical Research and Development (AMED); KAKENHI 21H04791, 21H051130, JPJSBP120213501, and JPJSBP120218801 from by the Japan Society for the Promotion of Science (JSPS); FOREST Program JPMJFR215T and JST Moonshot Research and Development Program JPMJMS2023 from Japan Science and Technology Agency (JST); Daiichi Sankyo Foundation of Life Science; Takeda Science Foundation; Ono Medical Research Foundation; The Uehara Memorial Foundation. Brian Kobilka is a Chan Zuckerberg Biohub Investigator.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - The M2 muscarinic receptor (M2R) is a prototypical G-protein-coupled receptor (GPCR) that serves as a model system for understanding GPCR regulation by both orthosteric and allosteric ligands. Here, we investigate the mechanisms governing M2R signaling versatility using cryo-electron microscopy (cryo-EM) and NMR spectroscopy, focusing on the physiological agonist acetylcholine and a supra-physiological agonist iperoxo, as well as a positive allosteric modulator LY2119620. These studies reveal that acetylcholine stabilizes a more heterogeneous M2R-G-protein complex than iperoxo, where two conformers with distinctive G-protein orientations were determined. We find that LY2119620 increases the affinity for both agonists, but differentially modulates agonists efficacy in G-protein and β-arrestin pathways. Structural and spectroscopic analysis suggest that LY211620 stabilizes distinct intracellular conformational ensembles from agonist-bound M2R, which may enhance β-arrestin recruitment while impairing G-protein activation. These results highlight the role of conformational dynamics in the complex signaling behavior of GPCRs, and could facilitate design of better drugs.
AB - The M2 muscarinic receptor (M2R) is a prototypical G-protein-coupled receptor (GPCR) that serves as a model system for understanding GPCR regulation by both orthosteric and allosteric ligands. Here, we investigate the mechanisms governing M2R signaling versatility using cryo-electron microscopy (cryo-EM) and NMR spectroscopy, focusing on the physiological agonist acetylcholine and a supra-physiological agonist iperoxo, as well as a positive allosteric modulator LY2119620. These studies reveal that acetylcholine stabilizes a more heterogeneous M2R-G-protein complex than iperoxo, where two conformers with distinctive G-protein orientations were determined. We find that LY2119620 increases the affinity for both agonists, but differentially modulates agonists efficacy in G-protein and β-arrestin pathways. Structural and spectroscopic analysis suggest that LY211620 stabilizes distinct intracellular conformational ensembles from agonist-bound M2R, which may enhance β-arrestin recruitment while impairing G-protein activation. These results highlight the role of conformational dynamics in the complex signaling behavior of GPCRs, and could facilitate design of better drugs.
UR - http://www.scopus.com/inward/record.url?scp=85146774432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146774432&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-35726-z
DO - 10.1038/s41467-022-35726-z
M3 - Article
C2 - 36690613
AN - SCOPUS:85146774432
SN - 2041-1723
VL - 14
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 376
ER -